Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Avecia Doubles RNA Production

May 21, 2007 | A version of this story appeared in Volume 85, Issue 21

Avecia's OligoMedicines business is expanding production of short interfering RNAs (siRNAs) at its Milford, Mass., facility. When completed by Sept. 1, the upgrade will, at the least, double capacity to 300-400 g per batch size in three areas: cleavage and deprotection, duplexation and conjugation, and chromatography. Avecia says the expansion will allow it to better address growing markets for siRNA- and aptamer-based therapeutics.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.